W. R. Berkley
WRB
$67.72
+0.24%
W.R. Berkley Corporation is an insurance holding company that underwrites commercial casualty insurance through its subsidiaries, specializing in niche products such as excess and surplus lines, workers' compensation, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses. As a market leader in the excess and surplus lines segment, the company differentiates itself through disciplined underwriting and a focus on specialized, non-standard risks. Currently, the investor narrative centers on the company's ability to sustain premium growth and underwriting profitability amid a competitive insurance market, with attention on its recent quarterly performance and the impact of pricing trends on future margins.…
WRB
W. R. Berkley
$67.72
Related headlines
Investment Opinion: Should I buy WRB Today?
Based on the analysis, WRB is rated a Hold. The stock offers a modest upside of 1.6% to the average analyst target of $69.53, with a consensus recommendation of 'hold'. The thesis is that WRB's strong ROE and defensive beta provide stability, but the decelerating growth and high PEG ratio limit upside potential.
Sign up to view all
WRB 12-Month Price Forecast
The AI assessment is neutral, reflecting balanced risks and rewards. WRB's defensive characteristics and strong ROE are positives, but the decelerating growth and high PEG ratio temper enthusiasm. The stock is likely to trade in a narrow range over the next 12 months, with the base case of $68-72 being most probable. An upgrade to bullish would require evidence of accelerating growth, such as revenue growth above 5% and improving margins, while a downgrade would be triggered by margin compression or a major catastrophe.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on W. R. Berkley's 12-month outlook, with a consensus price target around $69.53 and implied upside of +2.7% versus the current price.
Average Target
$69.53
0 analysts
Implied Upside
+2.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$51 - $83
Analyst target range
WRB is covered by 17 analysts, with a consensus recommendation of 'hold' and a mean recommendation score of 3.39 (where 1 is strong buy and 5 is sell). The average target price is $69.53, implying a modest upside of 1.6% from the current price of $68.44. The distribution of ratings is not provided, but the 'hold' consensus indicates a neutral stance, with recent actions from firms like Evercore ISI (Underperform) and Wells Fargo (Underweight) suggesting some bearish sentiment, while Goldman Sachs upgraded to Buy in June 2026. The target price range spans from a low of $51.00 to a high of $83.00, representing a wide spread of 62.7% from low to high, which signals significant uncertainty about WRB's future performance. The low target likely assumes margin compression or competitive losses, while the high target may reflect expectations of accelerating growth and multiple expansion. The wide range, combined with the hold consensus, suggests that analysts are divided on the stock's prospects, and investors should weigh the potential downside against the modest upside.
Drowning in data?
Find the real signal!
Bulls vs Bears: WRB Investment Factors
WRB presents a mixed picture: strong profitability (ROE 18.34%) and defensive characteristics (beta 0.294) are offset by decelerating growth and a high PEG ratio. The stock trades at a slight premium to its industry PE (15.65x vs 15.0x), but the forward PE of 14.14x suggests modest earnings growth expectations. The bear case currently has stronger evidence due to the decelerating revenue trend and analyst caution, but the low beta and solid cash flow provide a floor. The key tension is whether WRB can reaccelerate premium growth in a competitive market; if it does, the stock could re-rate higher, but if not, it may remain range-bound.
Bullish
- Strong ROE of 18.34%: WRB's return on equity is 18.34%, well above the industry average, indicating efficient capital deployment and strong underwriting profitability. This high ROE supports the stock's premium valuation relative to peers.
- Consistent Revenue Growth: Revenue has grown steadily from $3.31B in Q2 2024 to $3.69B in Q1 2026, with a 3.98% YoY increase in the latest quarter. The domestic segment, contributing $3.04B, provides a stable base, while reinsurance adds diversification.
- Low Beta Defensive Qualities: With a beta of 0.294, WRB is significantly less volatile than the market, making it a defensive holding. This low correlation to market swings is attractive for risk-averse investors seeking stability.
- Solid Free Cash Flow: Free cash flow TTM is $3.37B, providing ample liquidity for dividends, buybacks, and potential acquisitions. This financial flexibility supports shareholder returns and strategic initiatives.
Bearish
- High PEG Ratio of 7.63x: Despite a forward PE of 14.14x, the PEG ratio of 7.63x indicates the stock is expensive relative to its expected earnings growth of ~10.7%. This suggests the market is pricing in higher growth than currently projected.
- Decelerating Revenue Growth: Revenue growth has slowed from 11.3% YoY in Q4 2024 to just 3.98% in Q1 2026. This deceleration may signal a maturing market or increased competition, potentially pressuring future earnings.
- Underperformance vs Market: WRB is down 3.93% over the past year while the S&P 500 gained 18.56%, underperforming by over 22 percentage points. This relative weakness may persist if the market continues to favor growth stocks.
- Analyst Consensus Hold: With a mean recommendation of 3.39 (hold) and an average target price of $69.53, analysts see only 1.6% upside. Recent downgrades from Evercore ISI and Wells Fargo add to the bearish sentiment.
WRB Technical Analysis
WRB's price trend over the past year has been range-bound with a slight downward bias, as the stock is down 3.93% over the last 12 months. The current price of $68.44 sits at approximately 73% of its 52-week range (low of $62.87, high of $78.96), indicating a position closer to the lower end of the range, which may suggest a value opportunity or reflect ongoing bearish sentiment. The stock's beta of 0.294 indicates significantly lower volatility than the market, making it a defensive holding, but the price action has been lackluster relative to the S&P 500, which gained 18.56% over the same period.
Beta
0.29
0.29x market volatility
Max Drawdown
-19.0%
Largest decline past year
52-Week Range
$63-$79
Price range past year
Annual Return
-5.5%
Cumulative gain past year
| Period | WRB Return | S&P 500 |
|---|---|---|
| 1m | -6.6% | +2.0% |
| 3m | +3.7% | +1.0% |
| 6m | -2.7% | +11.8% |
| 1y | -5.5% | +18.1% |
| ytd | -2.4% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
WRB Fundamental Analysis
WRB's revenue growth has been modest but steady, with the most recent quarter (Q1 2026) reporting revenue of $3.69 billion, a 3.98% increase year-over-year. Over the past five quarters, revenue has grown from $3.31 billion in Q2 2024 to $3.69 billion in Q1 2026, reflecting a consistent but decelerating growth trajectory, with the latest YoY growth rate of 3.98% down from 11.3% in Q4 2024. The company's insurance segments, particularly the domestic segment which contributed $3.04 billion in revenue, are driving growth, while the reinsurance segment added $455 million, indicating a diversified revenue base. This growth, while positive, is slower than the broader market's expectations, and the investment case hinges on whether WRB can accelerate premium growth in a competitive pricing environment.
Quarterly Revenue
$3.7B
2026-03
Revenue YoY Growth
+4.0%
YoY Comparison
Gross Margin
47.5%
Latest Quarter
Free Cash Flow
$3.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is WRB Overvalued?
Given WRB's positive net income, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 15.65x, while the forward PE is 14.14x, implying that the market expects earnings growth of approximately 10.7% over the next year. This forward discount suggests a modestly optimistic outlook, but the PEG ratio of 7.63x indicates that the stock is expensive relative to its expected earnings growth, which is a red flag for value investors. Compared to the industry average PE of 15.0x (based on available data), WRB trades at a slight premium of 4.3%, which is justified by its strong ROE of 18.34% and consistent profitability. Historically, WRB's PE has ranged from 7.8x to 26.5x over the past five years, with the current 15.65x sitting near the middle of that range, suggesting that the stock is fairly valued relative to its own history, though the high PEG ratio warrants caution.
PE
15.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 10x~18x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks include a debt-to-equity ratio of 0.29, which is manageable but not negligible, and a current ratio of 1.39, indicating adequate liquidity. However, the net margin of 12.1% is relatively thin for an insurer, and any deterioration in underwriting discipline could compress it further. The payout ratio of 39.35% suggests dividend sustainability, but a significant earnings decline could force a cut. Revenue concentration in the domestic segment (82% of total) exposes WRB to regional economic downturns, while the reinsurance segment's volatility adds another layer of risk.
FAQ
The key risks include: 1) Decelerating revenue growth, which fell from 11.3% to 3.98% YoY, potentially indicating a maturing market. 2) High valuation relative to growth, as evidenced by the PEG ratio of 7.63x. 3) Competitive pressures in the excess and surplus lines market, which could compress margins. 4) Catastrophe risk, as a major disaster could significantly impact earnings. 5) Analyst sentiment is cautious, with a hold consensus and a wide target range of $51 to $83, reflecting uncertainty.
The 12-month forecast for WRB is range-bound, with a base case target of $68-72 (50% probability), a bull case of $75-83 (25% probability), and a bear case of $51-62 (25% probability). The most likely scenario is continued steady growth with revenue increasing 3-5%, keeping the stock near the average analyst target of $69.53. The bull case requires accelerated growth and favorable market conditions, while the bear case would be triggered by margin compression or a major catastrophe. Overall, the stock is expected to trade sideways with a slight upward bias.
WRB is fairly valued relative to its own history, with a trailing PE of 15.65x, near the midpoint of its 5-year range of 7.8x to 26.5x. Compared to the industry average PE of 15.0x, it trades at a slight premium of 4.3%, which is justified by its superior ROE. However, the PEG ratio of 7.63x indicates that the market is pricing in higher growth than currently expected, making it expensive on a growth-adjusted basis. The forward PE of 14.14x implies modest earnings growth of 10.7%, which is reasonable but not compelling.
WRB is a moderate buy for income-focused investors, but not for growth seekers. The stock offers a 2.52% dividend yield and low beta, providing downside protection, but the upside is limited to 1.6% based on the average analyst target. The high PEG ratio of 7.63x suggests the stock is overvalued relative to its growth prospects. However, its strong ROE and consistent cash flow make it a reasonable holding for a diversified portfolio. A better entry point would be below $65, where the risk/reward improves.
WRB is more suitable for long-term investment due to its defensive characteristics and income generation. With a beta of 0.294, it offers stability in volatile markets, and its dividend yield of 2.52% provides a steady income stream. The company's consistent profitability and strong ROE suggest it can compound value over time. Short-term trading is less attractive given the low volatility and limited upside potential. A minimum holding period of 3-5 years is recommended to fully benefit from dividend reinvestment and potential earnings growth.
